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Unplanned excision of soft tissue sarcomas (STSs) outside comprehensive tumor management centers necessitates the need for
wide reexcision to achieve adequate margins. We retrospectively reviewed medical records of 135 patients with STS operated at our
hospital with the goal of examining outcomes, in terms of local recurrence (LR) and metastasis rate (MR), of reexcision following
unplanned excision of STS and comparing results with those of first-time planned surgery. Eighty-four patients had their first-time
surgery and 51 patients had come to us following unplanned excision at prereferral hospital. Mean age of all patients was 41.8 ± 21.9
years. The LR and MR was 14.3% and 8.3%, respectively, in patients undergoing first resection, whereas it was 21.4% and 13.7%,
respectively, in patients undergoing revision surgery. Average duration from previous unplanned excision was 8 months. Twelve
patients were referred immediately after excised specimen revealed STS, while 39 patients presented after evident local recurrence.
Wide reexcision was attempted in 48 patients while three patients need amputation. Adjuvant radiotherapy was administered in all
patients undergoing limb-sparing surgery. Ten patients needed adjuvant chemotherapy. We conclude that wide reexcision of STS has
poorer outcomes compared to planned excision. Therefore, patients with soft tissue masses should be managed by multidisciplinary
oncology team at specialized cancer centers.

1. Introduction
Soft tissue sarcomas (STSs) are heterogeneous groups of
malignant mesenchymal tumors which comprise less than
1% of all malignancies [1]. The literature has reported that a
general physician may see one STS case in 24 years [2]. Meticulous workup in terms of radiological and histopathological
evaluation is required for diagnosis and planning a multidisciplinary treatment strategy. The standard treatment protocol
involves wide surgical resection along with neoadjuvant or
adjuvant radiotherapy [3].
In a developing country like ours, health care system is
still immature. Patients with limb swellings seek treatment
very late and often doctors are their last choice. Many end up
with general surgeons who still prefer to excise these without
any knowledge of proper margins [4]. Moreover, due to rarity
of soft tissue sarcomas coupled with low index of suspicion
for malignancy, these soft tissue masses are not evaluated

properly by radiological and histopathological examination
by general orthopedic surgeons. The patients diagnosed with
STS each year in USA are approximately 8700, whereas in
U.K., about 1500 new STS cases are diagnosed [5]. Bhurgri
et al. [6] reported that STS in Pakistan accounted for 2.9% and
1.6% of all cancers in males and females, respectively. They
also reported that although STS does not fall in 10 most common cancers of the region, Pakistan still falls into high risk
category for STS with male predominance [6]. In a country
of 180 million people, we only have three trained orthopedic
oncology surgeons. Consequently, such masses are excised
by inexperienced surgeons without consideration of malignancy. The risk of residual disease after such unplanned
excision is reported to be between 24%–60% in the literature
[7–12].
Patients with extremity lumps n bumps end up in an excision biopsy with the intent of removing a benign tumor.
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They are then referred to specialized tumor care centers when
the pathology of excised specimen reveals an STS or when
there is local recurrence. At this stage, various treatment
options can be offered to the patient. These include wide reresection followed by adjuvant therapy, radiotherapy alone or
amputation. Most studies favor wide re-resection along with
radiotherapy in a specialized tumor care center [10, 13, 14].
The purpose of this study was to examine the outcomes of
reexcision of residual STSs following an unplanned excision
and compare it, in terms of local recurrence and metastasis,
with outcomes of patients who underwent a single, planned
excision.

2. Patients and Methods
We conducted this retrospective cohort study at The Aga
Khan Hospital on consecutive patients coming to our hospital
from 1994 to 2008. The demographic data and clinical characteristics of the study population were acquired from clinical
chart review, tumor registry information, physicians’ records,
patients’ correspondence, and telephone interviews. Patients
were excluded if they had incomplete or missing medical
records. A total of 135 patients were thus included in the study.
Patients were divided into two groups. The “planned
excision” group consisted of 84 patients who were referred
to orthopedic oncologists at our institution without any prior
attempts at excision of tumor. The tumor was then excised
after proper staging workup and intraoperative frozen section
were done to confirm the diagnosis and margin status. The
“unplanned excision” group consisted of 51 patients who were
referred after a previous attempt to excise the tumor at some
other hospital. Reexcision was carried out for these patients
unless the tumor invasion was extensively involving the
neurovascular structures. Intraoperative pathologist was consulted to confirm the negative margins and diagnosis.
All tumors were reviewed by experienced pathologists at
our institution. Tumors were diagnosed and graded according to the FNCLCC (French Federation Nationale des Centres de Lutte Contre le Cancer) system [15]. For analyses,
FNCLCC grade 2 and 3 tumors were defined as high-grade
tumors, and grade 1 as a low grade one [16]. Tumor size was
classified as <5 cm or ≥5 cm. Tumors were characterized as
superficial or deep according to the involvement of the investing fascia [17]. Margins were evaluated intraoperatively by
a dedicated pathologist. Margins were inked and separately
sampled. The closest margin was microscopically categorized
as positive (tumor within 1 mm of the inked surface) or negative (absence of tumor within 1 mm of the inked surface) and
was further classified into the following categories: <4 mm,
5–9 mm, 10–19 mm, and ≥20 mm. Radiotherapy was recommended for patients with tumors exhibiting high risk factors
for recurrence: any one or combination of factors including
size >5 cm, high grade, deep tumors, inadequate surgical
mar-gins. Radiation therapy was given to the entire surgical
bed with 3 to 5 cm margin beyond the surgical scar and/or
beyond post-operative seroma or areas of ecchymoses. The
dose delivered was 50 Gy in 25 fractions using computed
tomography (CT-) based three-dimensional conformal treatment planning. The scar was bolused to ensure full dose to
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the surface. The field size was then reduced to the primary
surgical bed plus a 2 cm margin for a further dose of 10 Gy
in 5 fractions. If the margin was microscopically positive, a
further 6 Gy in 3 fractions was delivered to that area for a total
of 66 Gy in 33 fractions.
Statistical software SPSS version 20 was used for data
analysis. Chi square was used for categorical variables and t
test was used for continuous variables. A 𝑃 value of <0.05 was
considered to indicate statistical significance.

3. Results
During the study period, a total of 135 patients received
treatment at our institute. Mean age of the patients was 41.8 ±
21.9 years. There were 83 (61.5%) men and 52 (38.5%) women.
Histological diagnosis of tumor was made by taking biopsies
as recommended by NCCN guidelines. pleomorphic liposarcoma, synovial cell sarcoma, spindle cell sarcoma, and malignant fibrous histiocytoma were the most common tumor
types. The majority of the tumors were located in the lower
limb (67.4%). The clinical pathological characteristics of
patients are summarized in Table 1.

4. Group 1: Planned Excision
There were 84 patients in this group. Most of the patients
presented with asymptomatic swelling. The mean duration of
symptoms was 12 months. Most of the tumors were of high
grade (84.5%), ≥5 cm in size (59.5%), and deep seated (44%).
Eighteen tumors (21.4%), 28 (33.3%), 34 (40.5%), and 4
(4.8%) were categorized as having margin widths of 1–4 mm,
5–9 mm, 10–19 mm, and ≥20 mm, respectively. Postoperative
radiation was administered to 60 patients. Patients with prognostic factors indicating high risk for recurrence were recommended for radiation therapy.
The mean follow-up period (starting from the date of
surgery) was 52.6 ± 39.8 months (median 36 months). As
shown in Table 2, twelve patients (14.3%) developed local recurrence. Distant metastasis occurred in 7.3% of the patients.
Sixty-five patients were alive in this group at the end of the
study while 8 patients died during the followup.

5. Group 2: Unplanned Excision
There were 51 patients in this group. Average duration from
previous unplanned excision to wide reexcision was 8
months. 12 patients were referred immediately after excised
specimen revealed STS, while 39 patients presented after
evident local recurrence. Wide reexcision was attempted in
48 patients while three patients needed amputation. Adjuvant
radiotherapy was administered in all patients undergoing
limb sparing surgery. Additionally ten patients needed adjuvant chemotherapy. Most of the tumors in this group were of
high grade (84.3%), deep seated (50.9%), and <5 cm in size
(70.5%).
Minimum follow-up duration (starting from revision
surgery) was 36 months. As shown in Table 2, 11 (21.4%)
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Table 1: Clinical characteristics of patients.

Characteristics

Total 𝑁 = 135,
No. (%)

Planned surgery
𝑁 = 84, No. (%)

Unplanned surgery
Immediate 𝑁 = 12
Delayed 𝑁 = 39

All 𝑁 = 51

P value

Age

0.523

<45
≥45
Gender

75 (55.5%)
60 (44.5%)

Male
Female
Tumor site

83 (61.5%)
52 (38.5%)

Upper
Lower
Grade

44 (32.6%)
91 (67.4%)

1
2
3
Size

21 (15.5%)
42 (31.1%)
72 (53.4%)

<5 cm
>5 cm
Radio

47 (56.0%)
37 (44.0%)

28 (54.9%)
23 (45.1%)

6 (50%)
6 (50%)

22 (56.4%)
17 (43.6%)

0.696
0.039

46 (54.8%)
38 (45.2%)

37 (72.5%)
14 (27.5%)

9 (75%)
3 (25%)

28 (71.8%)
11 (28.2%)

0.828
0.207

25 (29.8%)
59 (70.2%)

19 (37.3%)
32 (62.7%)

2 (16.7%)
10 (83.3%)

17 (43.6%)
22 (56.4%)

0.092
0.152

13 (15.5%)
31 (36.9%)
40 (47.6%)

8 (15.7%)
11 (21.6%)
32 (62.7%)

4 (33.3%)
2 (16.7%)
6 (50%)

4 (10.3%)
9 (23%)
26 (66.7%)

0.158

34 (40.5%)
50 (59.5%)

36 (70.5%)
15 (29.5%)

12 (100%)
0 (0%)

24 (61.5%)
15 (38.5%)

0.011

47 (71.4%)
37 (28.6%)

48 (94.1%)
3 (5.9%)

11 (91.7%)
1 (8.3%)

37 (94.9%)
2 (5.1%)

0.680

0.001
70 (51.8%)
65 (48.2%)

0.000

Yes
No
Margin

95 (70.3%)
40 (29.7%)

1–4 mm
5–9 mm
10–19 mm
>20
Depth

29 (21.5%)
39 (28.9%)
58 (42.9%)
6 (4.4%)

Superficial
Deep

P value

0.447
18 (21.4%)
28 (33.3%)
34 (40.5%)
4 (4.8%)

11 (21.6%)
11 (21.6%)
24 (47.1%)
2 (3.9%)

5 (41.7%)
1 (8.3%)
6 (50%)
0 (0%)

6 (15.4%)
10 (25.6%)
18 (46.2%)
2 (5.1%)

0.203

47 (56.0%)
37 (44.0%)

25 (49.9%)
26 (50.9%)

9 (75%)
3 (25%)

16 (41.1%)
23 (58.9%)

0.040

0.504
72 (53.4%)
63 (46.6%)

Table 2: compares the outcomes of two groups.
Patients’ outcomes
Recurrence
Yes
No
Metastasis
Yes
No
Status
Dead
Alive

Total 𝑁 = 135, No. (%)

Planned surgery 𝑁 = 84, No. (%)

Unplanned surgery 𝑁 = 51, No. (%)

23 (17%)
112 (83%)

12 (14.3%)
72 (85.7%)

11 (21.5%)
40 (78.5%)

P value
0.275

0.319
14 (10%)
121 (90%)

7 (8.3%)
77 (91.7%)

7 (13.7%)
44 (86.3%)

15 (11%)
120 (89%)

8 (9.5%)
76 (91.5%)

7 (13.7%)
44 (86.3%)

0.679

patients developed local re-recurrence. Distant metastasis
occurred in 7 (13.7%) of the patients.

6. Discussion
The term “unplanned total excision” was first described by
Giuliano and Eilber [7]. Noria et al. [8] further described

this term with respect to soft tissue sarcoma as unplanned
resection of a lesion without using benefits of preoperative diagnostic modalities and without intention to achieve
tumor-free margins. The literature has suggested that such
resections result from the lack of awareness of standard soft
tissue sarcoma management and can cause of problem when
potential malignancy is not considered [3, 18].
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Soft tissue sarcomas have low incidence and can occur in
any part of the body. This leads physicians other than surgical
oncologists to resect these tumors with non-standardized
methods and without keeping a suspicion of malignancy in
mind [3, 18].
In order to avoid such unplanned resections, physicians
must be aware of the signs reported by the literature which
suggest malignancy. These signs include mass size >5 cm,
rapid increase in size of the mass, presence of mass deep
to fascia, pain in previously painless mass, and recurrent
swelling [3, 19]. The literature has reported several diagnostic
modalities such as biopsy, proper staging, and preoperative
imaging. These must be carried out in specialized sarcoma
centers. These modalities not only help in diagnosis but are
also of importance in avoiding incorrect surgical procedures
on these sarcomas [3, 18].
Pakistan is a third world country and its population is
different from others in terms of access to health centers,
awareness about the disease, and socioeconomic status. There
are only a few specialized cancer care centers in the country
with multidisciplinary approach towards these rare STSs.
Patients therefore end up going to improper health care personnel and getting the lesion excised without keeping in mind
the suspicion of malignancy and safe margins. By the time
they approach the specialized cancer care centers, they have
a poor prognosis. The presence of a multidisciplinary tumor
board is an integral part of multimodal therapy for malignant
diseases, particularly for sarcoma [4].
Once an unplanned excision has been carried out, there
is a need for reexcision by an experienced surgical oncologist.
The literature has also reported that surgical margins need
to be more extensive during reexcision as compared to conventional wide-margin excision because CT/MRI shows reactive changes post-operatively after first surgery and inappropriate skin incisions lead to contamination of neighboring
compartments. The purpose is to remove the residual tumor
and the neighboring tissue which was contaminated during
unplanned excision [3, 20]. Considering the large number of
cases with residual disease found in re-excised specimen
there is a need of single-planned surgery. Residual tumors
in re-excised specimen are associated with increased local
recurrence and metastasis [3].
The published literature has reported variable outcomes
when studying prognostic outcomes of patients who have
received the unplanned resection. Table 3 shows comparison
of the number of cases with residual tumor in various studies.
Lewis et al. [12] showed that disease specific metastasis-free
survival rate was lower in patients who underwent re-resection as compared to those who underwent planned primary
surgery. Fiore et al. [21] reported that there were no significant
differences in terms of local relapse, metastasis, and mortality
between the reexcision group and the primary planned surgery group. Ueda et al. [22] furthermore showed that patients
who received initial inadequate excision had higher local
recurrence rates as compared to those who had their planned
primary definitive surgery at the same institution. Our study
reported that local recurrence rate, metastasis rate, and mortality rate were higher in patients who underwent unplanned
resections, although the difference as compared to patients
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Table 3: Comparison the number of cases with residual tumors in
various studies.
Study

Total cases Reexcision (%) Residual tumor (%)

Noria et al. [8]

65

100

35

Davis et al. [9]

239

43

40

Fiore et al. [21]
Chandrasekar
et al. [10]
Venkatesan et al.
[3]

597

53

24

363

87

60

42

92.5

74

51

100

68.6

Our study

who underwent planned primary surgery was statistically
insignificant.
The loss of statistical significance between the outcomes
of the groups could be explained by selection and referral bias.
Smaller and superficial masses are more likely to be excised
by nonspecialist surgeon on the basis of assumption that they
are benign. Conversely, large and deep-seated tumors which
have potential worse prognosis are referred to a cancer care
center for the planned primary excision. However, in our
data, there was no statistical difference between the baseline
characteristics of the two groups (as detailed in Table 1).
Therefore, worse outcome of unplanned excision group could
not be attributed to the aggressiveness of tumors.
Although re-resection is an outcome to unplanned surgeries, it has its own costs. Patient’s affected limb function may
be reduced and complicated after re-resection as compared to
primary planned surgery due to the surgical approach used
during the re-resection. Secondly, unplanned surgery usually
leads to contamination of neighboring compartments with
the tumor cells so it becomes very difficult to ensure the complete removal of cancerous cells in reexcision. Furthermore,
the need for re-resection as early as possible leads to sparing
little time for neoadjuvant therapy which plays an important
part in the management of sarcoma patient [23].

7. Conclusion
Although the difference in rates of local recurrence and
metastasis between the two groups are statistically insignificant, a second surgery is translated into greater morbidity
in terms of pain, functional class of patient, aggressiveness,
technical difficulty of second surgery, prolonged length of
hospital stay, and cost of treatment as compared to planned
primary surgery. Therefore patients with soft-tissue masses of
unknown identity should be appropriately imaged, biopsied,
and managed by orthopedic oncologist at a specialized tumor
centre.
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